Effects of Quercetin on Cisplatin-Induced Renal Damage in Wistar Albino Rats

被引:3
作者
Cetinavci, Dilan [1 ]
Elbe, Hulya [2 ]
Taslidere, Elif [3 ]
Bostancieri, Nuray [4 ]
Taslidere, Asli [3 ]
机构
[1] Mugla Training & Res Hosp, Vitro Fertilizat Lab, Mugla, Turkey
[2] Mugla Sitki Kocman Univ, Dept Histol & Embryol, Fac Med, Mugla, Turkey
[3] Inonu Univ, Dept Histol & Embryol, Fac Med, Malatya, Turkey
[4] Gaziantep Univ, Fac Med, Dept Histol & Embryol, Gaziantep, Turkey
来源
NAMIK KEMAL MEDICAL JOURNAL | 2022年 / 10卷 / 02期
关键词
Cisplatin; quercetin; caspase-3; kidney toxicity; apoptosis; OXIDATIVE STRESS; NEPHROTOXICITY; PLATINUM; HYPOMAGNESEMIA; APOPTOSIS; PROTECTS; KIDNEY;
D O I
10.4274/nkmj.galenos.2022.24865
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim: Cisplatin is one of the effective antineoplastic drugs widely used in the treatment of many types of cancer. Cisplatin has harmful effects such as nephrotoxicity, ototoxicity and cardiomyopathy. Quercetin is an antioxidant of the flavonoid group. In this study, it was aimed to investigate the therapeutic effects of quercetin against cisplatin-induced kidney damage in rats. Materials and Methods: Twenty-eight male Wistar albino rats were randomly selected and divided into 4 groups: Group 1: Control (no application), Group 2: Quercetin (25 mg/kg/7 days/intraperitoneal), Group 3: Cisplatin (7 mg/kg/single dose/ intraperitoneal), Group 4: Cisplatin+quercetin (7 mg) /kg/single dose/ intraperitoneal cisplatin followed by 25 mg/kg/7 days/ intraperitoneal quercetin). After routine histological follow-up, hematoxylin eosin and periodic acid-schiff staining were performed. Histopathological damage score was calculated. Caspase-3 immunostaining was performed and scored. Results: Control and quercetin groups had normal histological appearance. In the cisplatin group, dilatation of the tubules, epithelial shedding, vacuolization of the tubular epithelial cells, and loss of microvilli in the proximal tubules were detected. In addition, infiltration areas were also found in places. In addition, an increase in caspase-3 immunostaining intensity was detected in this group (p=0.000). Histopathological findings were significantly reduced in the cisplatin+quercetin group compared to the cisplatin group (p=0.001). Conclusion: In this study, we think that quercetin is histopathologically beneficial in the treatment of cisplatin-induced kidney damage.
引用
收藏
页码:219 / 224
页数:6
相关论文
共 34 条
[21]   Quercetin protects the rat kidney against oxidative stress-mediated DNA damage and apoptosis induced by lead [J].
Liu, Chan-Min ;
Ma, Jie-Qiong ;
Sun, Yun-Zhi .
ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY, 2010, 30 (03) :264-271
[22]   Puerarin attenuates cisplatin-induced rat nephrotoxicity: The involvement of TLR4/NF-κB signaling pathway [J].
Ma, Xu ;
Yan, Lei ;
Zhu, Qing ;
Shao, Fengmin .
PLOS ONE, 2017, 12 (02)
[23]   PLATINUM NEPHROTOXICITY [J].
MADIAS, NE ;
HARRINGTON, JT .
AMERICAN JOURNAL OF MEDICINE, 1978, 65 (02) :307-314
[24]   Mechanisms of Cisplatin Nephrotoxicity [J].
Miller, Ronald P. ;
Tadagavadi, Raghu K. ;
Ramesh, Ganesan ;
Reeves, William Brian .
TOXINS, 2010, 2 (11) :2490-2518
[25]   INCREASE IN SERUM URIC-ACID LEVEL ASSOCIATED WITH CISPLATIN THERAPY - CORRELATION WITH LIVER BUT NOT KIDNEY PLATINUM CONCENTRATIONS [J].
NANJI, AA ;
MIKHAEL, NZ ;
STEWART, DJ .
ARCHIVES OF INTERNAL MEDICINE, 1985, 145 (11) :2013-2014
[26]   Quercetin impairs the reproductive potential of male mice [J].
Ranawat, P. ;
Kaushik, G. ;
Saikia, U. N. ;
Pathak, C. M. ;
Khanduja, K. L. .
ANDROLOGIA, 2013, 45 (01) :56-65
[27]   Quercetin reduces cisplatin nephrotoxicity in rats without compromising its anti-tumour activity [J].
Sanchez-Gonzalez, Penelope D. ;
Lopez-Hernandez, Francisco J. ;
Perez-Barriocanal, Fernando ;
Morales, Ana I. ;
Lopez-Novoa, Jose M. .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2011, 26 (11) :3484-3495
[28]   Quercetin, a bioflavonoid, protects against oxidative stress-related renal dysfunction by cyclosporine in rats [J].
Satyanarayana, PSV ;
Singh, D ;
Chopra, K .
METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY, 2001, 23 (04) :175-181
[29]   HYPOMAGNESEMIA AND RENAL MAGNESIUM WASTING IN PATIENTS RECEIVING CISPLATIN [J].
SCHILSKY, RL ;
ANDERSON, T .
ANNALS OF INTERNAL MEDICINE, 1979, 90 (06) :929-931
[30]   PATHOGENESIS OF HYPOCALCEMIA IN PRIMARY HYPOMAGNESEMIA - NORMAL END-ORGAN RESPONSIVENESS TO PARATHYROID-HORMONE, IMPAIRED PARATHYROID-GLAND FUNCTION [J].
SUH, SM ;
TASHJIAN, AH ;
MATSUO, N ;
PARKINSON, DK ;
FRASER, D .
JOURNAL OF CLINICAL INVESTIGATION, 1973, 52 (01) :153-160